CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Committee
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Online Early
Special Issues
Sample Issue
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
Referee Guidelines
Review Article
Annual Referee Index
For Advertisers
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook   youtube

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

 

Article << Previous     |     Next >>   Contents Vol 9(5)

The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance

Namraj Goire A B G, Kevin Freeman C, Stephen B. Lambert A B, Graeme R. Nimmo E F, Athena E. Limnios D, Monica M. Lahra D, Michael D. Nissen A B E, Theo P. Sloots A B E and David M. Whiley A B

A Queensland Paediatric Infectious Diseases Laboratory, Queensland Children’s Medical Research Institute, Children’s Health Service District, Brisbane 4029, Qld, Australia.
B Clinical Medical Virology Centre, Sir Albert Sakzewski Virus Research Centre, University of Queensland, Brisbane 4029, Qld, Australia.
C Microbiology Laboratory, Pathology Department, Royal Darwin Hospital, Darwin, NT 0811, Australia.
D World Health Organisation Collaborating Centre for STD, Microbiology Department, South Eastern Area Laboratory Services, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
E Microbiology Division, Pathology Queensland Central, Royal Brisbane and Women’s Hospital Campus, Brisbane 4029, Qld, Australia.
F Griffith University School of Medicine, Gold Coast, Qld 4222, Australia.
G Corresponding author. Email: namraj.goire@uqconnect.edu.au

Sexual Health 9(5) 422-429 http://dx.doi.org/10.1071/SH12026
Submitted: 8 March 2012  Accepted: 7 May 2012   Published: 5 October 2012
 
PDF (144 KB) $25
 Export Citation
 Print
  
Abstract

Background: With treatment options for gonorrhoea (Neisseria gonorrhoeae) diminishing, strengthening antimicrobial resistance (AMR) surveillance is paramount. Methods: In this study, we investigated polymerase chain reaction (PCR) based methods, in parallel with N. gonorrhoeae multi-antigen sequence typing (NG-MAST), for direct detection of four N. gonorrhoeae chromosomal mechanisms associated with emerging resistance to extended spectrum cephalosporins using noncultured samples: an adenine deletion in the mtrR promoter, a mosaic penicillin-binding protein (PBP) 2, an A501V PBP2 mutation, and alterations at positions 120 and 121 of the porB protein. The PCR assays were validated using a panel of characterised N. gonorrhoeae isolates (n = 107) and commensal Neisseria (n = 100) species. These PCR assays with NG-MAST were then applied to noncultured clinical specimens from distinct populations in Australia with differing levels of N. gonorrhoeae AMR: the Northern Territory (NT), where resistance has a low population prevalence, and Queensland (Qld), with higher AMR prevalence. Results: The real-time PCR assays proved highly sensitive and specific. When applied to the noncultured samples, only 1 out of 50 (2%) samples from NT harboured a resistant mechanism, whereas the Qld samples (n = 129) collected over different periods showed progressive acquisition of resistant mechanisms, and these were associated with specific NG-MAST types, including Type 225. Conclusions: The results suggest that our PCR-based methods could be used to rapidly pinpoint incursion of resistant strains into previously unaffected populations. Likewise, our results show that for molecular AMR surveillance, the population being investigated is as important as the genetic mechanisms being targeted.

Additional keywords: Australia, cephalosporin, gonorrhoea, penicillin, polymerase chain reaction.


References

[1]  Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis 2009; 22: 87–91.
| CrossRef |

[2]  Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538–45.
| CrossRef | CAS |

[3]  Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2011; 56: 1273–80.

[4]  Dillon JA. Sustainable antimicrobial surveillance programs essential for controlling Neisseria gonorrhoeae superbug. Sex Transm Dis 2011; 38: 899–901.
| CrossRef |

[5]  Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme 2010. Commun Dis Intell 2010; 2: 89–95.

[6]  Martin I, Jayaraman G, Wong T, Liu G, Gilmour M, Canadian Public Health Laboratory Network. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000–2009. Sex Transm Dis 2011; 38: 892–8.
| CrossRef | CAS |

[7]  Liao M, Gu WM, Yang Y, Dillon JA. Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone. J Antimicrob Chemother 2011; 66: 1016–23.
| CrossRef | CAS |

[8]  Takahata S, Senju N, Osaki Y, Yoshida T, Ida T. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 2006; 50: 3638–45.
| CrossRef | CAS |

[9]  Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother 2010; 65: 2141–8.
| CrossRef | CAS |

[10]  Golparian D, Hellmark B, Fredlund H, Unemo M. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex Transm Infect 2010; 86: 454–60.
| CrossRef |

[11]  Lindberg R, Fredlund H, Nicholas R, Unemo M. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 2007; 51: 2117–22.
| CrossRef | CAS |

[12]  Zhao S, Duncan M, Tomberg J, Davies C, Unemo M, Nicholas RA. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2009; 53: 3744–51.
| CrossRef | CAS |

[13]  Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S, et al Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 2005; 49: 137–43.
| CrossRef | CAS |

[14]  Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51: 3111–6.
| CrossRef | CAS |

[15]  Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, et al Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 2010; 54: 1060–7.
| CrossRef | CAS |

[16]  Tomberg J, Unemo M, Davies C, Nicholas RA. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 2010; 37: 8062–70.

[17]  Tapsall JW, Ray S, Limnios A. Characteristics and population dynamics of mosaic penA allele-containing Neisseria gonorrhoeae isolates collected in Sydney, Australia, in 2007–2008. Antimicrob Agents Chemother 2010; 54: 554–6.
| CrossRef | CAS |

[18]  Lee SG, Lee H, Jeong SH, Yong D, Chung GT, Lee YS, et al Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother 2010; 65: 669–75.
| CrossRef | CAS |

[19]  Goire N, Freeman K, Tapsall JW, Lambert SB, Nissen MD, Sloots TP, et al Enhancing gonococcal antimicrobial resistance surveillance: a real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J Clin Microbiol 2011; 49: 513–8.
| CrossRef |

[20]  Kugelman G, Tapsall JW, Goire N, Syrmis MW, Limnios A, Lambert SB, et al Simple, rapid, and inexpensive detection of Neisseria gonorrhoeae resistance mechanisms using heat-denatured isolates and SYBR green-based real-time PCR. Antimicrob Agents Chemother 2009; 53: 4211–6.
| CrossRef | CAS |

[21]  Goire N, Nissen MD, LeCornec GM, Sloots TP, Whiley DM. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis 2008; 61: 6–12.
| CrossRef | CAS |

[22]  Ochiai S, Ishiko H, Yasuda M, Deguchi T. Rapid detection of the mosaic structure of the Neisseria gonorrhoeae penA gene, which is associated with decreased susceptibilities to oral cephalosporins. J Clin Microbiol 2008; 46: 1804–10.
| CrossRef | CAS |

[23]  Whiley DM, Goire N, Ray ES, Limnios A, Lambert SB, Nissen MD, et al Neisseria gonorrhoeae multi-antigen sequence typing using non-cultured clinical specimens. Sex Transm Infect 2010; 86: 51–5.
| CrossRef |

[24]  Palmer HM, Young H, Graham C, Dave J. Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex Transm Infect 2008; 84: 280–4.
| CrossRef | CAS |

[25]  Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme 2003. Commun Dis Intell 2004; 28: 187–93.

[26]  Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme 2007. Commun Dis Intell 2008; 32: 227–31.

[27]  Monfort L, Caro V, Devaux Z, Delannoy AS, Brisse S, Sednaoui P. First Neisseria gonorrhoeae genotyping analysis in France: identification of a strain cluster with reduced susceptibility to ceftriaxone. J Clin Microbiol 2009; 47: 3540–5.
| CrossRef |

[28]  Mavroidi A, Tzelepi E, Siatravani E, Godoy D, Miriagou V, Spratt BG. Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing. J Clin Microbiol 2011; 49: 1196–1201.
| CrossRef | CAS |

[29]  Ferreira WA, Ferreira CM, Naveca FG, Almeida NC, Vasconcelos WDS, Gomes JDS, et al Genotyping of two Neisseria gonorrhoeae fluroquinolone-resistant strains in the Brazilian Amazon region. Mem Inst Oswaldo Cruz 2011; 5: 629–31.

[30]  Goire N, Ohnishi M, Limnios AE, Lahra MM, Lambert SB, Nimmo GR, et al Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. J Antimicrob Chemother 2011; 67: 902–905.


   
Subscriber Login
Username:
Password:  

 
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2013